TMJ Implants Fossa-Eminence Safety Summary Disputed With FDA
This article was originally published in The Gray Sheet
Executive Summary
TMJ Implants, Inc. continues to challenge FDA's reservations about the long-term safety of the Fossa-Eminence prosthesis system for partial reconstruction of the temporomandibular joint.
You may also be interested in...
TMJ Implants, Inc.' s Fossa-Eminence Not Approvable - FDA Dental Panel
Members of FDA's Dental Products Panel questioned the adequacy of safety and efficacy data supporting use of TMJ Implants' Fossa-Eminence prosthesis for partial reconstruction of the temporomandibular joint as a first-line therapy, in recommending against FDA approval of the device Oct. 6 in Rockville, Maryland.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.